Claquin P. 1990. Overview of Issues in the Sustainability of EPI. REACH Project. October. Arlington, Virginia: John Snow, Inc.

Cutts FT, Orenstein WA, Bernier RH. 1992a. Causes of low preschool immunization coverage in the United States. Annual Review of Public Health 13:385–398.

Cutts FT, Zell ER, Mason D, Bernier RH, Dini EF, Orenstein WA. 1992b. Monitoring progress towards U.S. preschool immunization goals. Journal of the American Medical Association 267:1952–1955.

Day LM. 1990. Toward Ensuring the Financial Sustainability of EPI. REACH Project. October. Arlington, Virginia: John Snow, Inc.

de Quadros CA, Carrasco P, Olive JM. 1992. Desired field performance characteristics of new improved vaccines for the developing world. Paper presented at the NIAID Conference on Vaccines and Public Health: Assessing Technologies and Global Policies for the Children's Vaccine Initiative, November 5–6, 1992, Bethesda, Maryland.


Freeman P, Johnson K, Babcock J. 1993. A health challenge for the states: Achieving full benefit of childhood immunization. Occasional Paper. February. The John W. McCormack Institute of Public Affairs, University of Massachusetts at Boston.


Hinman AR. 1991. What will it take to fully protect all American children with vaccines? American Journal of Disease Control 145:559–562.


Institute of Medicine. 1991. Malaria: Obstacles and Opportunities. Washington, D.C.: National Academy Press.

Institute of Medicine. 1986a. New Vaccine Development: Establishing Priorities. Volume I. Diseases of Importance in the United States. Washington, D.C.: National Academy Press.

Institute of Medicine. 1986b. New Vaccine Development: Establishing Priorities. Volume II. Diseases of Importance in the Developing World. Washington, D.C.: National Academy Press.

Institute of Medicine. 1992. Emerging Infections. Washington, D.C.: National Academy Press.

Kim-Farley R and The Expanded Programme on Immunization Team. 1992. Global immunization. Annual Review of Public Health 13:223–237.


Johnson KA. 1987. Who's Watching Our Children's Health? December. Washington, D.C.: Children's Defense Fund.


Liu JT, Rosenbaum S. 1992. Medicaid and Childhood Immunizations: A National Study. Children's Defense Fund. January. Washington, D.C.


Mahoney RT. 1990. Cost of plasma-derived hepatitis B vaccine production. Vaccine 8:397–402.

Maynard JE. 1989. Global control of hepatitis B through vaccination: Role of hepatitis B vaccine in the Expanded Programme on Immunization. Reviews of Infectious Diseases 11(Suppl. 3): S574–S578.


National Vaccine Advisory Committee. 1991. The measles epidemic. Journal of the American Medical Association 226:1547–1552.

National Vaccine Advisory Committee. 1992. Access to Childhood Immunizations: Recommendations and Strategies for Action. April. Rockville, Maryland.


Pan American Health Organization. 1992. Progress in the worldwide polio eradication effort. EPI Newsletter 14(6):1–2.

Pan American Health Organization. 1993. Global EPI progress reviewed. EPI Newsletter 15(1):6.

Peter G. 1992. Childhood immunizations. New England Journal of Medicine 327:1795–1800.

Plotkin SL Plotkin SA. 1988. A short history of vaccines. Vaccines, Plotkin SA and Mortimer EA, eds. Philadelphia: W.B. Saunders Company.

Poore P, Cutts F, Seaman J. 1993. Universal childhood immunization: Is it sustainable? Lancet 341:58.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement